Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential

Oral Oncology

Volumn 36, Issue 2, 2000, Pages 207-213

  Hong, Seong Doo ^a   Hong, Sam Pyo ^a   Lee, Jae Il ^a   Lim, Chang Yun ^a  

^a Seoul National University   (South Korea)

Author keywords

Gelatin zymography; Immunohistochemistry; Metastasis; MMP 2; MMP 9; Squamous cell carcinoma

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MOUTH CARCINOMA; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; ZYMOGRAPHY;

CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MOUTH NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM PROTEINS;

EID: 0034162024     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00088-3     Document Type: Article

References (29)

1. Spiro R.H., Alfonso A.E., Farr H.W., Strong E.W. Cervical lymph node metastasis from epidermoid carcinoma of oral cavity and oropharynx. American Journal of Surgery. 128:1974;562-567.
2. Fidler I.J., Radinsky R. Genetic control of cancer metastasis. Journal of National Cancer Institute. 82:1990;166-168.
3. Birkedal-Hansen H., Moore W.G.I., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., Engler J.A. Matrix metalloproteinases. A review. Critical Reviews of Oral Biology and Medicine. 4(2):1993;197-250.
4. Sato H., Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. Journal of Biochemistry. 119:1996;209-215.
5. Nakagawa T., Kubota T., Kabuto M., Fujimoto N., Okada Y. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase=gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix. Journal of Neurooncology. 28(1):1996;13-24.
6. Lengyel E., Gum R., Juarez J., Clayman G., Seiki M., Sato H., Boyd D. Induction of Mr 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. Cancer Research. 55:1995;963-967.
7. Shima I., Sasaguri Y., Kusukawa J., Yamana H., Fujita H., Kakegawa T., Morimatsu M. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. Cancer. 70:1992;2747-2753.
8. Kusugawa J., Sasakuri Y., Shima I., Kameyama T. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. American Journal of Clinical Pathology. 99:1993;18-23.
9. Charous S.J., Stricklin G.P., Nanney L.B., Burkey B.B. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Annals of Otology and Rhinology. 106:1997;271-278.
10. Kawamata H., Uchida D., Hamano H., Kimura-Yanagawa T., Nakashiro K.I., Hino S., Ometehara F., Yoshida H., Sato M. Active-MMP2 in cancer cell nests of oral cancer patients: correlation with lymph node metastasis. International Journal of Oncology. 13:1998;699-704.
11. Davies B., Miles D.W., Happerfield D.W., Naylor M.S., Balkwill F.R. Activity of type IV collagenases in benign and malignant breast disease. British Journal of Cancer. 67:1993;1126-1131.
12. Liotta L.A. Tumor invasion and metastases Role of extracellular matrix. Cancer Research. 46:1986;1-7.
13. Juarez J., Clayman G., Nakajima M., Tanabe K.K., Saya H., Nicolson G.L., Boyd D. Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity. International Journal of Cancer. 55:1993;10-18.
14. Allgayer H., Babic R., Beyer B.C., Grutzner K.U., Tarabichi A., Schildberg F.W., Heiss M.M. Prognostic relevance of MMP-2 (72-kD collagenase IV) in gastric cancer. Oncology. 55(2):1988;152-160.
15. Liabakk N.B., Talbot I., Smith R.A., Wilkinson K., Balkwill F. Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Research. 56(1):1996;190-196.
16. Musso O., Theret N., Campion J.P., Turlin B., Milani S., Grappone C., Clement B. In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasis. Journal of Hepatology. 26(3):1997;593-605.
17. Koshiba T., Hosotani R., Wada M., Miyamoto Y., Fujimoto K., Lee J.U., Doi R., Arii S., Imamura M. Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma. Cancer. 82(4):1998;642-650.
18. Miyajima Y., Nakano R., Morimatsu M. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. Annals of Otology Rhinology and Laryngology. 104:1995;678-684.
19. Yanagi H., Sasaguri Y., Suguma K., Morinatsu M., Nagase H. Production of tissue collagenase (matrix metalloproteinase 1) by human aortic smooth muscle cells in response to platelet-derived growth factor. Atherosclerosis. 91:1991;207-216.
20. Kerr L.D., Holt J.T., Matrisian L.M. Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science. 242:1988;1424-1427.
21. Bauer E.A., Cooper T.W., Huang J.S., Altman J., Deuel T.F. Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. Proceedings of National Academy of Science USA. 82:1985;4132-4136.
22. Overall C.M., Wrana J.L., Sodek J. Independent regulation of collagenase, 72 kDa progelatinase, and metalloproteinase inhibitor expression in human fibroblasts by transforming growth factor-β Journal of Biological Chemistry. 264(3):1989;1860-1869.
23. Parsons S.L., Watson S.A., Brown P.D., Colins H.M., Steele R.J.C. Matrix metalloproteinases. British Journal of Surgery. 84:1997;160-166.
24. Nakajima M., Welch D.R., Belloni P.N., Nicholson G.L. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Research. 47:1987;4869-4876.
25. Bernhard E.J., Muschel R.J., Hughes E.N. Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Research. 50:1990;3872-3877.
26. Salo T., Liotta L.A., Tryggvason K. Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells. Journal of Biological Chemistry. 258:1983;3058-3063.
27. Salo T., Turpeenniemi-Hujanen T., Tryggvason K. Tumor-promoting phorbol esters and cell proliferation stimulate secretion of basement membrane collagen-degrading metalloproteinase by human fibroblasts. Journal of Biological Chemistry. 60:1985;8526-8531.
28. Chen J.M., Aimes R.T., Ward G., Younglieb G.L., Quigley J.P. Isolation and characterization a 70-kDa metalloproteinase (gelatinase) that is elevated in Rous Sarcoma Virus-transformed chicken embryo fibroblasts. Journal of Biological Chemistry. 266:1991;5113-5121.
29. Mackay A.R., Hartzler J.L., Pelina M.D., Thorgeirsson U.P. Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen. Journal of Biological Chemistry. 265:1990;21929-21934.